Picture of Seegene logo

096530 Seegene Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Seegene, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line26,710503,147537,561182,432733
Depreciation
Amortisation
Non-Cash Items-1,381163,958171,159157,46615,812
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-7,841-300,444-410,606-78,83312,676
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities27,666383,157334,024319,00994,932
Capital Expenditures-4,786-175,268-66,112-72,452-31,879
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-2,128-17,404-36,561-31,528-246,447
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-6,915-192,672-102,673-103,980-278,327
Financing Cash Flow Items4,460-1,834-1,407-1,000
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-4,17971,905-110,302-144,501-156,700
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash16,498259,037124,00689,216-331,007